News & Updates

Climacteric women with eating disorders are more likely to exhibit night eating habits and experience more severe symptoms of menopause, as reported in a descriptive study.

Low-dose semaglutide may reduce alcohol craving and some drinking-related outcomes in patients with alcohol use disorder (AUD), a randomized clinical trial has shown.

A significant portion of Singapore’s youth are experiencing ‘severe’ to ‘extremely severe’ levels of depression and anxiety, according to the National Youth Mental Health Study.

The incidence of depression among older adults with type 2 diabetes is low, and the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) helps reduce the risk of depression relative to dipeptidyl peptidase-4 inhibitors (DPP4is), but not sodium–glucose cotransporter-2 inhibitors (SGLT2is).

The glucagon-like peptide 1 receptor agonist (GLP-1RA) semaglutide has the potential to reduce alcohol cravings and consumption in adults with alcohol use disorder (AUD), as shown in a phase II study.

Analysis of routine clinical data via machine learning show promise for predicting the progression to schizophrenia within 5 years among patients with pre-existing mental illness, as shown in a study.

Women with polycystic ovarian syndrome (PCOS) in their middle years are prone to exhibiting unfavourable eating behaviours, according to a study.

A retrospective cohort study has shown that short first-line treatments with therapist-guided, internet-delivered cognitive behavioural therapy (CBT) yield comparable outcomes as face-to-face CBT.